Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Shanghai Mental Health Center is the lead sponsor of 69 current clinical trials in our China register. 37 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Lemborexant and Venlafaxine. The most-studied condition is Schizophrenia.

ClinicalTrials.gov trials by status

Recruiting3754%
Not yet open2536%
Active, closed57%
By invitation23%

Trials by phase

Not applicable4565%
Observational1826%
Phase 423%
Phase 1/223%
Phase 211%
Phase 111%

Clinical trials sponsored by Shanghai Mental Health Center

69 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
The Effect of Game-Based Intervention on the Cognition of Schizophrenia Patients NCT07557381 · ClinicalTrials.gov ↗ · Schizophrenia	Not applicable	Recruiting	2026-04	China
The Efficacy of Temporal Interference Stimulation in the Treatment of Obsessive-Compulsive Disorder NCT07113652 · ClinicalTrials.gov ↗ · Obsessive-Compulsive Disorder (OCD)	Not applicable	Recruiting	2025-08	China
A Study on the Preference of Risperidone Dosage Forms NCT06657430 · ClinicalTrials.gov ↗ · Schizophrenia, Bipolar Affective Disorder, Autism Spectrum Disorder	Observational	Recruiting	2024-09	China
Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder NCT06457230 · ClinicalTrials.gov ↗ · Methamphetamine Use Disorder	Not applicable	Recruiting	2024-12	China
Efficacy and Influencing Factors of Mindfulness-Based Exposure Group Therapy for OCD NCT07484750 · ClinicalTrials.gov ↗ · Obessive-Compulsive Disorder	Not applicable	Recruiting	2026-02	China
Study on Deep Transcranial Magnetic Stimulation for Enhancing Insight NCT06831877 · ClinicalTrials.gov ↗ · Impaired Insight	Not applicable	Recruiting	2023-12	China
An ISO Principle-Based Music Intervention for Reducing Stress, Anxiety, and Depression NCT07055061 · ClinicalTrials.gov ↗ · Stress, Anxiety, Depression in Adults	Not applicable	Recruiting	2024-04	China
Non-invasive BCI and Application Verification for Depressed People NCT06417437 · ClinicalTrials.gov ↗ · Depression, Major Depressive Disorder, Bipolar Depression	Phase 4	Recruiting	2023-07	China
Cohort-Based Study of Diagnostic Biomarkers for Neurosyphilis NCT06680011 · ClinicalTrials.gov ↗ · Neurosyphilis, Biomarkers, Proteomics	Observational	Recruiting	2024-04	China
Effectiveness of MST Versus ECT for Major Depressive Episode NCT06409325 · ClinicalTrials.gov ↗ · Major Depressive Disorder (MDD)	Not applicable	Recruiting	2024-08	China
A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders NCT07417813 · ClinicalTrials.gov ↗ · Insomnia, Psychiatric Disorders Drug: Lemborexant	Observational	Recruiting	2026-01	China
RTMS for CHR Based on Personalized Targets Using Magnetoencephalography NCT06802952 · ClinicalTrials.gov ↗ · Clinical High-risk Syndrome of Psychosis	Not applicable	Recruiting	2025-02	China
Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder NCT07031544 · ClinicalTrials.gov ↗ · Obsessive - Compulsive Disorder	Not applicable	Recruiting	2024-12	China
A Study for the Disrupted Interpersonal Interaction Among Gaming Disorder Individuals and Treatment NCT06208358 · ClinicalTrials.gov ↗ · Gaming Disorder	Not applicable	Recruiting	2023-09	China
Efficacy and Mechanism of Augmentation of Cognitive Behavioral Therapy With Transcranial Alternating Current Stimulation(tACS) for Obsessive-Compulsive Disorder (OCD) NCT06717165 · ClinicalTrials.gov ↗ · Obsessive Compulsive Disorder (OCD)	Not applicable	Recruiting	2024-04	China
Dual-target iTBS for Youth With ADHD NCT07084649 · ClinicalTrials.gov ↗ · ADHD	Phase 1/2	Recruiting	2025-01	China
Neural Mechanisms of Temporal Interference Stimulation on Improving Social Reward Function in Depression NCT07287878 · ClinicalTrials.gov ↗ · Depression	Not applicable	Recruiting	2025-11	China
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia NCT02640911 · ClinicalTrials.gov ↗ · Schizophrenia	Observational	Recruiting	2010-11	China
Online FBT-DBT Caregiver Intervention for Caregivers of Individuals With Anorexia Nervosa NCT07734779 · ClinicalTrials.gov ↗ · Anorexia Nervosa, Caregiver Burden	Not applicable	Recruiting	2026-04	China
A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder NCT07031661 · ClinicalTrials.gov ↗ · High-risk, Bipolar Disorder, Atypical Depression	Observational	Recruiting	2024-10	China
Mechanisms of Deep Transcranial Magnetic Stimulation in Enhancing Cognitive-Behavioral Therapy for Anorexia Nervosa NCT06942858 · ClinicalTrials.gov ↗ · Feeding and Eating Disorders	Not applicable	Recruiting	2025-04	China
Transcranial Electrical Stimulation for Comorbid Depression and Chronic Pain NCT07334561 · ClinicalTrials.gov ↗ · Depression Disorder, Chronic Pain	Not applicable	Recruiting	2026-11	China
Pragmatic Trial of Obsessive-compulsive Disorder NCT04539951 · ClinicalTrials.gov ↗ · Obsessive-Compulsive Disorder Drug: Venlafaxine	Phase 2	Recruiting	2020-09	China
Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD NCT06942494 · ClinicalTrials.gov ↗ · Obsessive - Compulsive Disorder	Not applicable	Recruiting	2025-04	China
The Efficacy and Safety of Temporal Interference Stimulation in the Treatment of Post-Traumatic Stress Disorder NCT07644338 · ClinicalTrials.gov ↗ · Post-traumatic Stress Disorder (PTSD)	Not applicable	Recruiting	2026-06	China
Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents NCT06904079 · ClinicalTrials.gov ↗ · Severe Mental Disorder, Schizophrenia, Schizoaffective Disorder	Not applicable	Recruiting	2024-03	China
A Study to Evaluate the Effectiveness of Group Gaming Interventions for Individuals With Problematic Gaming Behavior and Gaming Disorder. NCT07363850 · ClinicalTrials.gov ↗ · Gaming Disorder	Not applicable	Recruiting	2025-10	China
Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis NCT06754319 · ClinicalTrials.gov ↗ · Obsessive-Compulsive Disorder, Tic Disorder	Observational	Recruiting	2024-08	China
Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders NCT06112067 · ClinicalTrials.gov ↗ · Deep Brain Stimulation	Not applicable	Recruiting	2023-10	China
Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia NCT07557368 · ClinicalTrials.gov ↗ · Schizophrenia	Not applicable	Recruiting	2026-04	China
Efficacy of Triple-daily 15mA tACS on Adolescent NSSI NCT06919432 · ClinicalTrials.gov ↗ · Self-Injurious Behavior	Not applicable	Recruiting	2025-05	China
Effect of High-Intensity Transcranial Alternating Current Stimulation on Gambling Disorder: A Randomized Controlled Trial NCT07228182 · ClinicalTrials.gov ↗ · Gambling Disorder	Not applicable	Recruiting	2026-06	China
RTMS for Refractory Auditory Hallucinations Based on Personalized Targets Using Magnetoencephalography NCT06802939 · ClinicalTrials.gov ↗ · Refractory Auditory Hallucinations, Schizophrenia	Not applicable	Recruiting	2025-02	China
Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia NCT05159349 · ClinicalTrials.gov ↗ · Schizophrenia	Observational	Recruiting	2021-12	China
Chinese Community Sample of Hierarchical Model of Psychopathology NCT06105970 · ClinicalTrials.gov ↗ · Mental Health Issue, Adverse Childhood Experience	Observational	Recruiting	2023-09	China
Efficacy of Hi-tACS for Schizophrenia Negative Symptoms NCT06888726 · ClinicalTrials.gov ↗ · Schizophrenia; Negative Type, Transcranial Alternating Current Stimulation	Not applicable	Recruiting	2024-06	China
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Using Sentiment Analysis Technology Based on Multi-modal Feature Fusion NCT07573839 · ClinicalTrials.gov ↗ · Bipolar Disorder (BD), Healthy Control	Observational	Recruiting	2026-04	China
High Intensity Alternating Current Stimulation as a Neuromodulation Therapy for Alcohol Use Disorder: A Pilot Study NCT07227545 · ClinicalTrials.gov ↗ · Alcohol Use Disorder (AUD)	Not applicable	Not yet open	2025-12	China
Closed-loop TBS Targeting rPO for the Core Clinical Features of the Methamphetamine Use Disorder NCT07775807 · ClinicalTrials.gov ↗ · Methamphetamine Use Disorder, Substance Use Disorder, Cue-reactivity	Not applicable	Not yet open	2026-08	China
Multimodal Cohort Study of Generalized Anxiety Disorder NCT07764211 · ClinicalTrials.gov ↗ · Generalized Anxiety Disorder (GAD)	Observational	Not yet open	2026-08	China
Pilot Evaluation of a Psychoeducation Group for Family Caregivers of Children and Adolescents With Emotional and Behavioral Disorders (CPG-CA) in China NCT06900465 · ClinicalTrials.gov ↗ · Emotional and Behavioral Disorders in Children and Adolescents	Not applicable	Not yet open	2025-06	China
The Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals With Tiletamine Use Disorder NCT07689981 · ClinicalTrials.gov ↗ · Tiletamine Use Disorder, Substance Use Disorder (SUD), Drug Craving	Not applicable	Not yet open	2026-07	China
The Effect of Immersive Virtual Reality Treatment With Cognitive Behaviour Therapy for Obsessive-Compulsive Disorder NCT04534907 · ClinicalTrials.gov ↗ · Obsessive-Compulsive Disorder, Virtual Reality	Not applicable	Not yet open	2025-12	China
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation NCT07767526 · ClinicalTrials.gov ↗ · Schizophrenia, Antipsychotic Drug	Phase 1/2	Not yet open	2026-10	China
Validation of the Accuracy of an AI-Based System for Diagnosing Depressive Disorders NCT07311668 · ClinicalTrials.gov ↗ · Depressive Disorder	Observational	Not yet open	2026-02	China
The Efficacy of an AI-Based Rehabilitation Treatment in Patients With Anxiety Disorders NCT07545070 · ClinicalTrials.gov ↗ · Anxiety Disorders	Not applicable	Not yet open	2026-04	China
Neural Mechanisms of the Sensorymotor Circuit in Sensory Phenomena in OCD NCT07480408 · ClinicalTrials.gov ↗ · Obsessive - Compulsive Disorder	Not applicable	Not yet open	2026-05	China
Tracking Risk in Adolescents and Children for Early Identification of Common Mental Disorders NCT07744490 · ClinicalTrials.gov ↗ · High Risk, Depression / Major Depressive Disorder, Anxiety Disease	Observational	Not yet open	2026-07	China
Efficacy and Mechanisms of TUS on Cognitive Deficits in Schizophrenia: Based on the Hippocampal-Prefrontal Circuit NCT06904092 · ClinicalTrials.gov ↗ · Cognitive Deficit in Schizophrenia	Not applicable	Not yet open	2026-07	China
Transcutaneous Electrical Acupoint Stimulation Combined With Exposure and Response Prevention in the Treatment of Patients With Obsessive-Compulsive Disorder: A Randomized Controlled Trial NCT07811778 · ClinicalTrials.gov ↗ · Obsessive Compulsive Disorder (OCD)	Not applicable	Not yet open	2026-09	China
Closed-loop TMS for the Core Clinical Features of the Methamphetamine Use Disorder NCT07154160 · ClinicalTrials.gov ↗ · Methamphetamine Use Disorder, Substance Use Disorder, Cue-reactivity	Not applicable	Not yet open	2026-08	China
HD-tACS for Alcohol Use Disorder NCT07808190 · ClinicalTrials.gov ↗ · Alcohol Use Disorder	Not applicable	Not yet open	2026-09	China
Validation of the Accuracy of an AI-Based System for Diagnosing Anxiety Disorders NCT07311655 · ClinicalTrials.gov ↗ · Anxiety Disorders	Observational	Not yet open	2026-02	China
Study of Neural Stem Cell-Derived Exosomes in Moderate-to-Severe Early-Onset Alzheimer's Disease NCT07554872 · ClinicalTrials.gov ↗ · Alzheimer Disease (AD)	Phase 1	Not yet open	2026-05	China
Home-Based Wearable rTMS Therapy for Moderate to Severe Depression NCT07775586 · ClinicalTrials.gov ↗ · Major Depressive Disorder	Not applicable	Not yet open	2026-08	China
Multi-target TMS for Schizophrenia Negative Symptoms NCT07559084 · ClinicalTrials.gov ↗ · SCHIZOPHRENIA 1 (Disorder)	Not applicable	Not yet open	2026-10	China
iMORE+ Study: A Multi-Omics Cohort Study of Major Depressive Disorder NCT07735143 · ClinicalTrials.gov ↗ · Major Depressive Disorder (MDD)	Observational	Not yet open	2027-09	China
Exploring the Efficacy of Accelerated Transcranial Direct Current Stimulation (tDCS) as Adjunct to Pharmacotherapy in the Treatment of Obsessive-compulsive Disorder NCT07115615 · ClinicalTrials.gov ↗ · Obsessive Compulsive Disorder (OCD)	Not applicable	Not yet open	2025-08	China
Closed-loop tTIS Targeted of the Nac as an Intervention for MUD Patients NCT07802223 · ClinicalTrials.gov ↗ · Amphetamine Use Disorders	Not applicable	Not yet open	2026-09	China
Transcranial Temporal Interference Stimulation Targeted of the Amygdala as an Intervention for Alcohol Use Disorder Patients NCT07472673 · ClinicalTrials.gov ↗ · Alcohol Use Disorder	Not applicable	Not yet open	2026-02	China
Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia NCT06700967 · ClinicalTrials.gov ↗ · Schizophenia Disorder	Observational	Not yet open	2024-12	China
A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms NCT07715994 · ClinicalTrials.gov ↗ · Extrapyramidal Symptoms, Drug-induced Parkinsonism, Akathisia, Drug-Induced	Observational	Not yet open	2026-07	China
Unique Electroencephalography (EEG) Markers of Habit Behaviors in Obsessive-Compulsive Disorder (OCD) NCT06882902 · ClinicalTrials.gov ↗ · Obsessive-Compulsive Disorder	Not applicable	By invitation	2024-05	China
Investigation on Risk Factors for Suicide Among Chinese Patients With Mood Disorders NCT07281729 · ClinicalTrials.gov ↗ · Bipolar Disorder；Major Depressive Disorder；Mood Disorders	Observational	By invitation	2025-08	China
TACS Intervention for Methamphetamine Addiction NCT06288997 · ClinicalTrials.gov ↗ · Methamphetamine Use Disorder	Not applicable	Active, closed	2021-11	China
Clinical Study of Compound Ciwujia Granules in the Treatment of Depression NCT07085143 · ClinicalTrials.gov ↗ · Depression - Major Depressive Disorder, Depression Disorders	Phase 4	Active, closed	2025-10	China
Establish a Specific Cohort Database for Depressive Disorders NCT05095662 · ClinicalTrials.gov ↗ · Depressive Disorder	Observational	Active, closed	2021-06	China
The Intervention Effect and Potential Neural Mechanisms of Music Therapy in Children and Adolescents With Mood Disorders NCT06756698 · ClinicalTrials.gov ↗ · Mood Disorders in Children and Adolescents	Not applicable	Active, closed	2024-07	China
Transcranial Ultrasound Stimulation as a Neuromodulation Therapy for Craving and Relapse Behaviors in Alcohol Use Disorder. NCT06867224 · ClinicalTrials.gov ↗ · Alcohol Use Disorder (AUD), Transcranial Ultrasound Stimulation	Not applicable	Active, closed	2025-03	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Shanghai Mental Health Center trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Lemborexant1 Venlafaxine1

Conditions in Shanghai Mental Health Center trials

80 conditions

Schizophrenia8 Obsessive-Compulsive Disorder4Methamphetamine Use Disorder4Obsessive - Compulsive Disorder4Obsessive Compulsive Disorder (OCD)3Alcohol Use Disorder (AUD)2Substance Use Disorder2Cue-reactivity2Craving2Depression2 Major Depressive Disorder2 Major Depressive Disorder (MDD)2Gaming Disorder2Depressive Disorder2Anxiety Disorders2Alcohol Use Disorder2Obsessive-Compulsive Disorder (OCD)1Bipolar Affective Disorder1Autism Spectrum Disorder1Conduct Disorder1Obessive-Compulsive Disorder1Generalized Anxiety Disorder (GAD)1Impaired Insight1Stress1

By trial register

Register	Trials	Recruiting
Clinical trials in China	69	37

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Schizophrenia

Sponsor	Trials
Bristol-Myers Squibb	7
China Medical University Hospital	7
Central South University	7
Neurocrine Biosciences	6
University of Pittsburgh	3
Vigonvita Life Sciences	3
Luye Pharma Group	3
Tianjin Anding Hospital	3
Vanda Pharmaceuticals	2
Karuna Therapeutics, Inc., a Bristol Myers Squibb company	2

Sponsors with the most current trials registered for this condition.

Questions about Shanghai Mental Health Center trials

How many clinical trials does Shanghai Mental Health Center sponsor?

Shanghai Mental Health Center is the lead sponsor of 69 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Shanghai Mental Health Center trials recruiting?

Yes. 37 of its 69 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Shanghai Mental Health Center testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Lemborexant (1) and Venlafaxine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Shanghai Mental Health Center clinical trials